These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15552624)

  • 1. Congress investigates FDA's handling of antidepressant safety information.
    Young D
    Am J Health Syst Pharm; 2004 Nov; 61(21):2228, 2230, 2232 passim. PubMed ID: 15552624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antidepressants and suicide -- did the FDA Black Box Warning back fire?].
    Rihmer Z
    Psychiatr Hung; 2014; 29(3):252-6. PubMed ID: 25411222
    [No Abstract]   [Full Text] [Related]  

  • 3. Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data.
    Barbui C; Cipriani A; Geddes JR
    Evid Based Ment Health; 2008 May; 11(2):34-5. PubMed ID: 18441126
    [No Abstract]   [Full Text] [Related]  

  • 4. Suicidality in adolescents being treated with antidepressant medications and the black box label: position paper of the Society for Adolescent Medicine.
    Lock J; Walker LR; Rickert VI; Katzman DK;
    J Adolesc Health; 2005 Jan; 36(1):92-3. PubMed ID: 15702497
    [No Abstract]   [Full Text] [Related]  

  • 5. Pediatric antidepressant use after the black-box warning.
    Busch SH; Barry CL
    Health Aff (Millwood); 2009; 28(3):724-33. PubMed ID: 19414881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' views on suicidality and antidepressants.
    Muroff JR; Kim SY
    Psychiatr Serv; 2006 May; 57(5):723-4. PubMed ID: 16675775
    [No Abstract]   [Full Text] [Related]  

  • 7. Antidepressants and the FDA's black-box warning: determining a rational public policy in the absence of sufficient evidence.
    Ho D
    Virtual Mentor; 2012 Jun; 14(6):483-8. PubMed ID: 23351264
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA post-marketing safety decisions.
    Klein DF
    J Clin Psychiatry; 2006 Aug; 67(8):1305-6. PubMed ID: 16965212
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA rejects first cognitive claim for antidepressant.
    Mullard A
    Nat Rev Drug Discov; 2016 May; 15(5):299. PubMed ID: 27139989
    [No Abstract]   [Full Text] [Related]  

  • 10. The FDA's generic-drug approval process: similarities to and differences from brand-name drugs.
    Kefalas CH; Ciociola AA
    Am J Gastroenterol; 2011 Jun; 106(6):1018-21. PubMed ID: 21637264
    [No Abstract]   [Full Text] [Related]  

  • 11. The revised warning for antidepressants and suicidality: unveiling the black box of statistical analyses.
    Leon AC
    Am J Psychiatry; 2007 Dec; 164(12):1786-9. PubMed ID: 18056231
    [No Abstract]   [Full Text] [Related]  

  • 12. Suicidality as a possible side effect of antidepressant treatment.
    Culpepper L; Davidson JR; Dietrich AJ; Goodman WK; Kroenke K; Schwenk TL
    J Clin Psychiatry; 2004 Jun; 65(6):742-9. PubMed ID: 15291649
    [No Abstract]   [Full Text] [Related]  

  • 13. Antidepressants & suicide: putting the risk in perspective.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2007 Jul; 45(7):15-9. PubMed ID: 17679311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.
    Gupta S; Gersing KR; Erkanli A; Burt T
    Psychiatr Q; 2016 Jun; 87(2):329-42. PubMed ID: 26303613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA's Rx for better medication information.
    Farley D
    FDA Consum; 1995 Nov; 29(9):5-10. PubMed ID: 10152787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopharmacology news.
    Silva RR
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):531-2. PubMed ID: 17822347
    [No Abstract]   [Full Text] [Related]  

  • 17. Pediatricians and antidepressant medications: black box or black hole?
    Wegner LM
    Pediatrics; 2005 Jul; 116(1):233-5. PubMed ID: 15995060
    [No Abstract]   [Full Text] [Related]  

  • 18. Vortioxetine (Brintellix®) and levomilnacipran (Fetzima®): the two newest additions to the antidepressant formulary.
    Roman MW; Wilkinson SM
    Issues Ment Health Nurs; 2014 Dec; 35(12):972-4. PubMed ID: 25426751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxetine and the FDA.
    Connor DF
    J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):127. PubMed ID: 14726715
    [No Abstract]   [Full Text] [Related]  

  • 20. Thinking outside the (black) box: antidepressants, suicidality, and research synthesis.
    Greenhouse JB; Kelleher KJ
    Pediatrics; 2005 Jul; 116(1):231-3. PubMed ID: 15995059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.